GenSci Seeking To Stay Injunction Of DynaGraft Gel, Putty Products
This article was originally published in The Gray Sheet
GenSci is planning to appeal a Los Angeles jury's $14.5 mil. damage award to Osteotech for patent infringement through the sale of its DynaGraft Gel and Putty bone products
You may also be interested in...
Osteotech will cease production of its bio-d threaded cortical bone dowel system by Jan. 31, 2003 under a patent infringement settlement with Medtronic's Sofamor Danek unit, announced April 30
Butterfly Network chose SPAC route with Longview Acquisition Corp. to scale its business and expand into the home market in 2021.